Regulatory Pharma NetRegulatory Pharma Net, regulatory affairs pharma.#Regulatory #affairs #pharma

Posted On Jun 12 2018 by

regulatory affairs pharma OUR GOAL IS TO EXCEED YOUR EXPECTATIONS OUR SERVICES Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing Reimbursement, Market Access Global and Local Regulatory Affairs Strategic Advice and Due Diligence Pricing & Reimbursement and Market Access Pharmacovigilance eCTD and Regulatory Procedures Management Medical Devices Project Management Orphan Drug Applications Pharmaceutical, Preclinical and Clinical Development Clinical Trial Applications Quality Management and Auditing Scientific / Medical Writing Product Information and Readability Testing Life Cycle Management Training Biocides, Food Supplements and Cosmetics ABOUT US Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale EVENTS Discover next …


Pharma News, PharmaTutor, pharma news today.#Pharma #news #today

Posted On Jun 12 2018 by

Pharma News Posted on: 13 November 2017 By: admin In last month, there was lot of hike about osemertinib is being sold illegally in the Hyderabad by private and government hospitals despite a ban by the Drug Controller General of India (DCGI). But on last Friday, DCGI confirmed that only AstraZeneca Pharma India Limited, Bangalore has given permission for import and marketing of cancer drug. Read more about Astrazeneca s osemertinib is only approved in India Log in or register to post comments USFDA Expands Approval of Sprycel® (dasatinib) for children with Philadelphia chromosome Posted on: 11 November 2017 By: …


Pharmaceutical Company in India, Ahmedabad, Pharma Company in India, Cadila Pharmaceuticals, pharmaceutical healthcare companies.#Pharmaceutical #healthcare #companies

Posted On Jun 12 2018 by

Formulations A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 ISO14001 accredited facilities at Ankleshwar, India Innovation Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse Manufacturing Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA About us Cadila Pharmaceuticals Limited, established in …


Registration, 2018 BIO International Convention, top biotech companies 2013.#Top #biotech #companies #2013

Posted On Jun 12 2018 by

Join us in Boston for BIO 2018 Registration for BIO 2018 will open on or around January 29, 2018. New 2018 rates will be posted online as soon as they are confirmed. Explore BIO 2017 online: Registration Packages We offer several registration packages at different price points. Find the one that meets your needs and budget. Group registration is not offered. Here is a handy PDF of our 2017 Registration Packages. Need help? Convention Access Partnering $2,400 members $3,000 non-members What’s Included Convention Access Partnering is essentially your all access pass to the entire Convention. Register for this package to …


Pharma Bro locked up with terrorism and mob suspects, Fox Business, pharma business.#Pharma #business

Posted On Jun 12 2018 by

Pharma Bro locked up with terrorism and mob suspects By TOM HAYS Published September 15, 2017 Markets Martin Shkreli The three charges are very vulnerable to attack Former Turing Pharmaceuticals CEO Martin Shkreli on being found guilty of two charges of fraud and one charge of conspiracy. NEW YORK Inmate No. 87850-053 has no internet. Continue Reading Below That could be the least of the inconveniences ahead for Pharma Bro Martin Shkreli, whose online rantings about Hillary Clinton prompted a judge this week to revoke his bail and put him in the Metropolitan Detention Center, a fortress-like federal jail that …


SIMPEX 2017, pharmaceutical healthcare companies.#Pharmaceutical #healthcare #companies

Posted On Jun 12 2018 by

SIMPEX PARTNERS STRATEGIC PARTNER POST SANCTIONS ERA – Sudan Presents An Ocean of Opportunities Post lifting of US Trade sanctions, ​​Sudan ​is ​purs​u​​ing​ a strategy of establishing itself as a hub for Arab-African trade.​ The decision is set to ​drastically improve the business environment and drive the growth of Sudan’s economy​.​ In particular, ​the ability to transfer funds in and out of the country, previously restricted for both US and non-US companies, is set to ​give a major thrust to the business as more and more banks recommence processing Sudan-linked payments.​ Since last few weeks there has been a huge …


Aspire Pharmaceuticals, pharma business.#Pharma #business

Posted On Jun 12 2018 by

Welcome To Aspire Aspire Pharmaceuticals is a global leader in soft gelatin manufacturing. Our stringent procurement operations backed with rigorous analytics and testing infrastructure provides custom solutions for our clients from concept to delivery. We are here to guide our clients to innovate better all while optimizing their product journey. As industry trailblazers we are constantly looking to think beyond the status quo. About Us Our Mission As a leader in the development and manufacturing of soft gelatin nutritional supplements, we take that role with pride. Our singular vision starts with a question. How can we do it better? This …


10th Annual Pharmaceutical Regulatory Affairs Summit Asia 2017 – IBC Asia, an Informa business, regulatory affairs pharma.#Regulatory #affairs #pharma

Posted On Jun 12 2018 by

regulatory affairs pharma With a 9-year track record of successfully bringing to market the latest developments and insights from decision makers, the Pharma Regulatory Affairs Summit remains the only such conference in Asia. Part of the PharmaCon suite of events, the conference affords you the opportunity of getting hot of the press information and networking across various pharma industry segments. “Met regulatory affairs from various companies across Asia and exchanged information regarding issues we have faced in registering the product.” Astuti Kurniati, Associate Principal Regulatory Specialist, PT Dexa Medical Conference Highlights: Regional Government updates on initiatives, reducing backlogs, new guidelines …


Startseite – CAS Pharmaceuticals – From Research to Market, ETH Z – rich, arch pharma.#Arch #pharma

Posted On Jun 12 2018 by

Navigationsbereich mit dem Studiengang Pharmaceuticals – From Research to Market Industrie-spezifisches Wissen vermitteln gegen 100 Referierentinnen und Referenten aus Industrie, Consulting und von den Behörden. Transfer-orientierte Kursinhalte sind ein Schwerpunkt dieses Studiengangs. Absolvierende dokumentieren in der Abschlussarbeit, wie sie Kursinhalte in die Praxis umsetzen. Einstieg bei jedem Modul möglich Die Kursmodule finden im Zentrum von Zürich und Basel statt. Interdisziplinäres Wissen vermittel dieser Studiengang branchenspezifisch in regulatorischen, ökonomischen, rechtlichen und technischen Gebieten. CAS Pharmaceuticals – From Research to Market Die Pharmaindustrie gilt als eine der innovativsten und profitabelsten Branchen der Schweizer Wirtschaft. Wer in diesem dynamischen Umfeld erfolgreich sein will, …


Home Page, PhRMA, pharmaceutical healthcare companies.#Pharmaceutical #healthcare #companies

Posted On Jun 12 2018 by

pharmaceutical healthcare companies PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the Resource …